Founder & CEO
Kirthika Parmeswaran is a seasoned business & technology innovation executive with extensive experience in products, sales and strategy. She holds an Executive Masters in Technology Management degree from University of Pennsylvania – Wharton School of Business and a Masters in Computer Science from Washington University in St.Louis.
Co-Founder & Chief Scientific Advisor
Dr. John Chuo, MD, MSBI, IA is a Neonatal Quality Officer and Clinical Champion for Digital Health Valuation at the Children’s Hospital of Philadelphia. John is an Associate Professor of Clinical Pediatrics at the Perelman School of Medicine and the chair of SPROUT (Supporting Pediatric Research on Outcomes and Utilization of Tele-health) national research collaborative. He has a Masters in Biomedical Informatics from Harvard & MIT and prior entrepreneurial experience.
Lisa Wittmer, PhD is the COO & Head of Portfolio Development at AMO Pharma with extensive experience in pharmaceutical products. She is currently the Entrepreneur-in-Residence at PCI Ventures*. She has a doctorate from Washington University School of Medicine in St. Louis and has been a Howard Hughes Medical Institute Fellow at Duke University School of Medicine.
Ryan Mendoza manages a portfolio of IT, physical sciences, and hardware companies at PCI Ventures and advises on growth, business strategy, and fundraising. Prior to PCI Ventures, Ryan was SVP of Engineering and co-founder of Graphene Frontiers, a nanotechnology startup company. He has a M.S. in Electrical Engineering with a focus on nanoscale electronic systems from the University of Pennsylvania, and a B.S. in Electrical Engineering from the University of Southern California.